Pediatric myoclonic epilepsy is a chronic condition with diverse causes, including brain lesions, diffuse lesions, and systemic metabolic intoxication. Currently, localization repair therapy can repair damaged neuron cells, restore brain neuron cell function, balance abnormal discharges, and achieve the purpose of completely preventing epilepsy seizures. At the same time, patients can also control clinical symptom attack through oral medication.